Symbol Search
Browse Symbols
My Charts Menu
F.A.Questions
Suggestion Box
Advertising Info
Commodity Charts
Forex Markets
|
Akero Therapeutics Inc AKRO
Stock price quote for Akero Therapeutics Inc, symbol AKRO, Nasdaq Stock Exchange.
Quote data is updated continously during trading hours.
Akero Therapeutics Inc Symbol: AKRO Exchange: NSDQ
|
Most Recent Activity |
Activity Today |
Yearly Statistics |
|
|
|
All market data is delayed by 15 minutes.
Stock price quotations are updated continuously. Click reload to refresh this display.
[Daily],
[Weekly]
and [Monthly] stock price charts are available for Akero Therapeutics Inc
Most Recent HeadlinesIPR: May 9th, 2024, 19:03Length: 5968 GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
IPR: May 8th, 2024, 21:06Length: 5972 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
IPR: May 7th, 2024, 15:06Length: 5970 ROSEN, A TOP RANKED LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
BIZ: May 7th, 2024, 14:02Length: 5472 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
IPR: May 6th, 2024, 17:49Length: 5938 ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
BIZ: May 6th, 2024, 12:06Length: 5037 The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
BIZ: May 6th, 2024, 12:00Length: 4621 INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
IPR: May 4th, 2024, 20:35Length: 5957 AKRO INVESTOR ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
BIZ: May 3rd, 2024, 10:00Length: 4400 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors
BIZ: May 2nd, 2024, 21:29Length: 5212 Akero Therapeutics, Inc. (AKRO) Investor Notice: Robbins LLP Reminds Stockholders of the Akero Therapeutics, Inc. Class Action
Market data delivered to TradingCharts.com, Inc. by Barchart.com.
Although it is believed that information provided is accurate, no guarantee is made.
|
|